18F-DOPA PET in Sarcoma Patients

Overview

Información sobre este estudio

The purpose of this study is to identify early response biomarkers from biological or functional imaging to better align with clinical trial endpoints and minimize sarcoma patient toxicities.

 

 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

- PRE-ELIGIBILITY - INCLUSION CRITERIA:

- Age >= 18 years

- Histological confirmation of newly diagnosed high-grade soft tissue sarcoma, or
recurrent high-grade soft tissue sarcoma >= 1-year post-treatment

- Tumors > 1 cm in diameter in largest dimension located midline within the torso or
neck, retroperitoneal, or lower extremities

- Operable sarcoma, planning to receive surgery with or without neoadjuvant
RT/chemotherapy at Mayo Clinic Florida. Systemic therapy is allowed during
radiotherapy

- Provide informed written consent

- Willingness to participate in mandatory imaging studies at Mayo Clinic Florida

Exclusion Criteria:

- POST-ELIGIBILITY - EXCLUSION CRITERIA:

- 18F-DOPA PET uptake deemed as unacceptable for quantitative assessment

- Unable to undergo an 18F-DOPA PET/MRI scan due to standard MRI restrictions, such as
for those with certain implanted devices, those who cannot fit inside the bore, or
those with severe claustrophobia

- Any of the following:

- Pregnant women

- Nursing women

- Men or women of childbearing potential who are unwilling to employ adequate
contraception

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/12/2024. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Deanna Pafundi, Ph.D.

Abierto para la inscripción

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publicaciones

Publications are currently not available
.
CLS-20531574

Mayo Clinic Footer